// App-Quantinova.ai

13503 : Relative Efficacy of Alirocumab, Bempedoic Acid, Evolocumab, Ezetimibe and Inclisiran Added to Statins for Reduction of Low Density Lipoprotein Cholesterol - A Network Meta-Analysis of Randomized Clinical Trials

Researchers

Presenter

  • Peter P Toth

Principal Investigators

  • Sarah Bray

  • Gavin Worth

Medical Centers

  • Johns Hopkins University School of Medicine, Baltimore, MD

  • Amgen, Ltd., Uxbridge, United Kingdom

  • Amgen (Europe) GmbH,Rotkreuz,Switzerland

Locations

  • United States

  • United Kingdom

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Cholesterol

Drug/Treatment

  • ESP55016

  • Alirocumab

  • Evolocumab

  • Ezetimibe

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved